This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Oncology  • Breast Cancer  • Genetic Disorders  • Alert me on articles by topic

Noah D. Kauff, MD; Kenneth Offit, MD, MPH

JAMA. 2007;297:2637-2639.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Starting even before the identification of the BRCA1 and BRCA2 cancer susceptibility genes, several models were well established as predictors of a woman's risk of inherited breast cancer.¹ During the past decade, these models have been refined not only to predict breast cancer risk, but also to predict the likelihood that an individual carries a deleterious mutation in one of these genes. Such models have been used as criteria for offering genetic testing,² for determining eligibility for screening and prevention trials,³ and, increasingly, for assessing appropriateness of participation in incremental risk-reduction strategies.^4-5 Illustrating the influence modeling is having on clinical practice, the American Cancer Society recently issued guidelines for offering screening breast magnetic resonance imaging, which, among other criteria, stated that women with a lifetime risk of breast cancer of "20-25% or greater, as determined by BRCAPRO or other models that are . . . [Full Text of this Article]

Author Affiliations: Clinical Genetics Service, Department of Medicine (Drs Kauff and Offit), and Gynecology Service, Department of Surgery (Dr Kauff), Memorial Sloan-Kettering Cancer Center, New York, NY.

RELATED ARTICLE

Limited Family Structure and BRCA Gene Mutation Status in Single Cases of Breast Cancer
Jeffrey N. Weitzel, Veronica I. Lagos, Carey A. Cullinane, Patricia J. Gambol, Julie O. Culver, Kathleen R. Blazer, Melanie R. Palomares, Katrina J. Lowstuter, and Deborah J. MacDonald
JAMA. 2007;297(23):2587-2595.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How Should Women With Early-Onset Endometrial Cancer Be Evaluated for Lynch Syndrome?
Kauff
JCO 2007;25:5143-5146.
FULL TEXT  

Limited Family Tree Affects Breast Cancer Risk Assessment
JWatch Women's Health 2007;2007:4-4.
FULL TEXT